XML 51 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Incentive Plans (Tables)
 12 Months Ended
Jan. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Recognized Stock-based Compensation Expense The Company recognized stock-based compensation expense related to its equity incentive plans as follows (in thousands):
Year Ended January 31,
202120222023
Cost of revenue:
Subscription
$1,213$2,819$2,676
Professional services and other
8431,7531,822
Sales and marketing
10,93621,24130,636
Research and development
9,09515,85324,335
General and administrative
11,21818,15523,680
Interest expense
444705710 
Total
$33,749 $60,526 $83,859 
Schedule of Outstanding Stock Options and Related Activity The following table sets forth the outstanding common stock options and related activity for the years ended January 31, 2021, 2022 and 2023:
Shares
Subject to Outstanding Options		Weighted- Average Exercise
Price per Share		Weighted-Average Remaining Contractual Term (years)Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 20201,745,415 $23.91 4.6$5,152 
Exercised(374,049)21.64 
Forfeited(2,112)27.96 
Expired(72,751)37.53 
Outstanding as of January 31, 20211,296,50323.793.751,339
Exercised(332,137)16.92 
Forfeited(1,009)28.20 
Expired(69)40.02 
Outstanding as of January 31, 2022963,28826.16 2.920,166
Exercised(47,389)18.17
Expired(39,615)30.48
Outstanding as of January 31, 2023876,284$26.401.9$59
Vested and exercisable at January 31, 2023875,242$26.391.9$59
Schedule of Outstanding RSUs and Related Activity The following table sets forth the outstanding RSUs and related activity for the years ended January 31, 2021, 2022 and 2023:
Number of Shares Weighted- Average Grant Date Fair Value
Outstanding as of January 31, 20202,176,805 $23.40 
Granted3,209,165 25.94 
Vested(1,028,734)21.71 
Canceled(499,075)23.22 
Outstanding as of January 31, 20213,858,161 25.97 
Granted2,540,946 77.98 
Vested(1,681,544)25.37 
Canceled(378,944)40.42 
Outstanding as of January 31, 20224,338,61955.40 
Granted2,314,57139.46 
Vested(1,630,656)51.26 
Canceled(1,128,440)53.27 
Outstanding as of January 31, 20233,894,094$48.27 
Schedule of Weighted-average Assumptions Used in Determining Grant-date Fair Value of ESPP Purchase Rights The fair value of the purchase rights for the ESPP are estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:
Year Ended January 31,
202120222023
Expected stock price volatility
49% - 83%
41% - 82%
60% - 90%
Expected term
0.5 - 2.0 years
0.5 - 1.0 year
0.5 - 1.0 year
Risk-free interest rate
0.11% - 0.23%
0.04% - 0.09%
1.09% - 4.05%
Expected dividend yield–––